In this episode, we’ll be hearing from GU cancer experts about some of the biggest prostate cancer data presented at the ASCO Genitourinary Cancers Symposium 2023, including TRITON3, CheckMate650, and FORMULA-509. We’ll also be hearing perspectives on some of the hot topics in the field, such as treatment sequencing and combination therapies, unanswered questions for the use of PSMA PET in the staging of disease, and the use of active surveillance in localized prostate cancer.

Join Alan Bryce, MD, Mayo Clinic, Rochester, MN, Russell Kent Pachynski, MD, Washington University School of Medicine, St. Louis, MO, Paul Nguyen, MD, Dana-Farber Cancer Institute, Boston, MA, Silke Gillessen, MD, Oncological Institute of Southern Switzerland, Bellinzona, Switzerland, David Nanus, MD, Weill Cornell Medicine and New York Presbyterian Hospital, New York City, NY, and Anthony Victor D’Amico, MD, PhD, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Boston, MA, as they discuss the latest developments in prostate cancer.